TTY Biopharm Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - TTY Biopharm Co Ltd

Watchlist Manager

Watchlist

Price: 74.4 TWD -1.33% Market Closed

Market Cap: NT$18.5B

T	TTY Biopharm Co Ltd TPEX:4105	TW
R	Rogers Communications Inc SWB:RCIB	CA
	Record PLC LSE:REC	UK
	First American Financial Corp NYSE:FAF	US
	Chalice Mining Ltd ASX:CHN	AU
	Linedata Services SA PAR:LIN	FR
L	Lixil Corp TSE:5938	JP

Profitability Summary

TTY Biopharm Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

58%

Strong 3Y Average Gross Margin

58%

Declining Gross Margin

59% > 58%

Healthy Operating Margin

27%

Sustainable 3Y Average Operating Margin

25%

Operating Margin is Increasing

24% > 27%

Healthy Net Margin

25%

Sustainable 3Y Average Net Margin

23%

Net Margin is Increasing

21% > 25%

Exceptional Free Cash Flow Margin

27%

Strong 3Y Average Free Cash Flow Margin

21%

Free Cash Flow Margin is Increasing

21% > 27%

Exceptional ROE

25%

Positive 3Y Average ROE

Positive 3Y Average ROIC

17%

ROIC is Increasing

15% > 18%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.